Extended spectrum β-lactamases in Haemophilus?

Australian Journal of Medical Science

Volumn 20, Issue 2, 1999, Pages 33-41

  Tristram, S ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

lactam; lactamase; Cephalosporin; Enterobacteriaceae; Extended spectrum lactamase; Haemophilus; Minimum inhibitory concentration; Plasmid

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DNA TRANSPOSITION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMID; REVIEW;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE;

EID: 0032845986     PISSN: 10381643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Brecher SM. The role of humans in the re-evolution of bacteria. Clin Microbiol Newslett 1997; 19: 8: 61-64.
2. Sanders CC, Sanders WE. β-Lactam resistance in Gram negative bacteria: Global trends and clinical impact. Clin Inf Dis 1992; 15: 824-839.
3. Livermore D. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 4: 557-584.
4. Mathew M. Plasmid mediated β-lactamases of Gram negative bacteria: properties and distribution J Antimicrob Chemother 1979; 5: 349-358.
5. Tristram S. Extended spectrum β-lactamases: are we losing the battle? Aust J Med Sci 1995; 16: 16-25.
6. Dimopoulou ID, Kraak WAG, Anderson EC, Nichols WW, Slack MPE, Crook DW. Molecular epidemiology of unrelated clusters of multiresistant strains of Haemophilus influenzae. J Int Dis 1992; 165: 1069-1075.
7. Medeiros AA, O'Brien TF, Ampicillin resistant Haemophilus influenzae type b possessing a TEM type β-lactamase but little permeability barrier to ampicillin. Lancet 1975; 1: 7909: 716-718.
8. Stuy JH. Plasmid transfer in Haemophilus influenzae. J Bacteriol 1979; 139: 520-529.
9. Willard JE, Johnson EJ, Daum RS. Interrelationships between physical state phenotypic stability and transferability of βlactamase genes in Haemophilus influenzae. J Gen Microbiol 1982; 128: 2353-2360.
10. Murphey-Corb M, Nolan-Willard M, Daum RS. Integration of plasmid DNA coding for β-Lactamase production in the Haemophilus influenzae chromosome. J Bacteriol 1984; 160: 815-817.
11. Brunton J, Clare D, Meier MA. Molecular epidemiology of antibiotic resistance plasmids in Haemophilus species and Neisseria gonorrhoeae. Rev Inf Dis 1986; 8: 713-724.
12. Levy J, Verhaegen G, De Mol P, Couturier M, Dekegel D, Butzler JP. Molecular characterisation of resistance plasmids in epidemiologically unrelated strains of multiresistant Haemophilus influenzae. J Inf Dis 1993; 168: 177-187.
13. Mendelman PM , Doroshow CA, Gandy SL, Syriopoulou V, Weigen CP, Smith A. Plasmid mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis molecular characterisation of one strain and review of the literature. J Inf Dis 1984; 150: 30-39.
14. Williams JD, Moosdeen F. Antibiotic resistance in Haemophilus influenzae: epidemiology mechanisms and therapeutic possibilities. Rev Int Dis 1986; 8: (Suppl 5) S555-S561.
15. Campos J, Chanyangam M, de Groot R, Smith AL, Tenover FC, Reig R. Genetic relatedness of antibiotic resistance determinants in multiply resistant Haemophilus influenzae. J Inf Dis 1989; 160: 810-817.
16. Anderson JR, Smith MD, Kibbler CC, Holton J, Scott GM. A nosocomial outbreak due to non-encapsulated Haemophilus Influenzae Analysis of plasmids coding for antibiotic resistance. J Hosp Infect 1994; 27: 17-27.
17. Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended spectrum β-Lactamases. Antimicrob Agents Chemother 1991; 35: 164-169.
18. Sirot D, De Champs C, Chanal C, Labia R, Darfeuille-Michaud A, Perroux R, Translocation of antibiotic resistance determinants including an extended spectrum β-Lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 1991; 35: 1576-1581.
19. Sirot D, Sirot J, Labia R, Morand A, Courvalin P, Darfeuille-Michaud A. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1 a novel β-lactamase. J Antimicrob Chemother 1987; 20: 323-334.
20. Jacoby G, Bush K. Amino acid sequences for TEM, SHV and OXA extended spectrum β-lactamases. Retrieved via Netscape (13 August 1997) http//www..lahey.org/studies/webt.htm
21. Jones R. The antimicrobial activity of cefotaxime: comparative multi-national hospital isolate surveys covering 15 years Infection 1994; 22: (Suppl 3) S152-60.
22. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med 1995: 99 (Suppl 6B) 3S-7S.
23. Jorgensen J. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1993; 14: 1119-1123.
24. Powell M. Antimicrobial resistance in Haemophilus influenzae. J Med Microbiol 1988; 27: 81-87.
25. Collignon PJ, Bell JM, Maclnnes SJ, Gilbert GL, Toohey M. A national collaborative study of resistance to antimicrobial agents in Haemophilus influenzae in Australian hospitals The Australian Group for Antimicrobial Resistance (AGAR). J Antimicrob Chemother 1992; 30: 153-163.
26. Hussey GD, Coetzee G, Hitchcock J, van-Schalkwyk E, van-Wyk H, Kibel M. Carriage of Haemophilus influenzae in Capetown children. S Afr Med J 1994; 84: 135-137.
27. Wiedemann B, Peter K. Induction of β-lactamase in Gram negative bacteria. Diagn Microbiol Infect Dis 1989; 12: 131S-137S.
28. Powell M. Chemotherapy for infections caused by Haemophilus influenzae: current problems and future prospects. J Antimicrob Chemother 1991; 27: 3-7.
29. McManus P, Hammond ML, Whicker SD, Primrose J G, Mant A, Fairall SR. Antibiotic use in the Australian community 1990-1995. Med J Aust 1997; 167: 124-127.
30. Cough J, Kraak WA, Anderson EC, Nichols W, Slack M, McGhie D. Cross infection by non-encapsulated Haemophilus influenzae. Lancet 1990; 336: 159-160.
31. Sturm AW, Mostert R, Rouing P, van Klingeren B, van Alphen L. Outbreak of multiresistant Haemophilus influenzae infections in a pulmonary rehabilitation centre. Lancet 1990; 335: 214-215.
32. Heath T, Hewitt M, Jalaludin B, Roberts C, Capon A, Jelfs P, Invasive Haemophilus influenzas type b disease in elderly nursing home residents two related cases. Emerg Inf Dis 1997; 3: 179-182.
33. Sanchez L Puig M, Fuste C, Loren JG, Vinas M. Outer membrane permeability of non typable Haemophilus influenzae. J Antimicrob Chemother 1996; 37: 341-344.
34. James PA, Reeves DS. Bacterial resistance to cephalosporms as a function of outer membrane permeability and access to their target. J Chemother 1996; 8: (Suppl 2) 37-47.
35. Bradford PA, Sanders CC. Development of test panel of βlactamases expressed in common Escherichia coli host background for evaluation of new β-lactam antibiotics. Antimicrob Agents Chemother 1995; 39: 308-313.
36. Burns J L, Smith AL. A major outer membrane protein functions as a porin m Haemophilus influenzae. J Gen Microbiol 1987; 133: 1273-1277.
37. Mendelman PM, Chaffin DO, Krilov LR, Kalaitzoglou G. Penicillin binding proteins and ampicillin resistance in Haemophilus influenzae. J Antimicrob Chemother 1990; 25: 525-534.
38. Mendelman PM, Chaffin DO, Krilov LR, Kalaitzoglou G, Serfass DA, Onay O. Cefuroxime treatment failure of non-typable Haemophilus influenzae meningitis associated with alteration of penicillin binding proteins. J M Dis 1990; 162: 1118-1123.
39. James PA, Hossain F K, Lewis DA, White DA. β-lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime. J Antimicrob Chemother 1993; 32: 239-246.
40. Philippon A, Redjeb B, Fournier G, Hassen B. Epidemiology of extended spectrum β-lactamases. Infection 1989; 17: 347-354.
41. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. 6th Ed. Approved Standard. NCCLS Document M2-A6 Villanova Pa:NCCLS 1997.
42. Fuchs PC, Barry AL. Interpretative criteria for susceptibilities of Haemophilus influenzae to ampicillin amoxycillin and amoxycillin-clavulanic acid. J Clin Microbiol 1994; 32: 2846-2850.
43. Scriver SR, Hoban DJ, McGeer A, Moore TC, Walmsley SL, Low DE. Surveillance of susceptibility testing methodologies for Haemophilus influenzae in Canada including evaluation of disc diffusion test. J Clin Microbiol 1994; 32: 2013-2015.
44. Turk DC. The pathogenicity of Haemophilus influenzae. J Med Microbiol 1984; 18: 1-16.
45. Finch RG. Epidemiological features and chemotherapy of community acquired respiratory tract infections. J Antimicrob Chemother 1990; 26: 53-61.
46. Kaplan S L. Serious paediatric infections. Am J Med 1990; 88: (Suppl 4A) 18S-24S.
47. Klugman KP. Pneumococcal Resistance to Antibiotics. Clin Microbiol Rev 1990; 3: 171-196.
48. Turnidge J, Bell J, Collignon P. The battle against antibiotic resistance. Microbiology Australia 1996; 3: 27-31.
49. Fung-Tomc J. Fourth generation cephalosporins. Clin Microbiol Newslett 1997; 19: 129-136.
50. Nikaido H, Normark S. Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: a quantitative predictive treatment. Mol Microbiol 1987; 1: 29-36.
51. Waley S G. An explicit model for bacterial resistance: application to β-lactam antibiotics. Microbiol Sci 1987; 4: 143-146.
52. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 1220 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-198.
53. Palzkill T, Botstein D. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 β-lactamase. J Bacteriol 1992; 174: 5237-5243.